Risk Factors and Prognosis of Adverse Cardiovascular and Kidney Events After Coronary Intervention

Coronary Artery Disease Clinical Trial

Official title: Risk Factors and Prognosis of Adverse Cardiovascular and Kidney Events After Coronary Intervention

Status Completed

Clinical Trial Summary

As a single center, retrospective observation study in Guangdong Institute of Cardiovascular Diseases, this study included the main study population of patients who underwent coronary angiography and / or coronary intervention from January 2007 to Decemeber 2018. The hospitalization information was collected in the form of direct derivation of the case, and cardiac and renal adverse events were collected through outpatient recorder system. All-cause death information was obtained from the Public Security and matched to the electronic Clinical Management System of the Guangdong Provincial People's Hospital records.

Clinical Trial Description

This is a single center, retrospective observation study collecting data on 88938 coronary angiography and / or coronary intervention patients from January 2007 to Decemeber 2018. Data regarding demographic information, admission diagnoses and history of present illness, biomarkers and details on preventive hydration and medications will be collected. The primary endpoint of this study is All-cause mortality, and secondary endpoints are Adverse Cardiovascular and Kidney Events. ;

Related Conditions & MeSH terms

• Cardio-Renal Syndrome
• Coronary Angiography
• Coronary Artery Disease
• Kidney Diseases
• Metabolic Syndrome
• Syndrome

• NCT number: NCT04407936
• Study type: Observational
• Source: Guangdong Provincial People's Hospital
• Status: Completed
• Start date: June 1, 2007
• Completion date: March 10, 2020